Cushing Syndrome
Endocrinology
5
Pipeline Programs
3
Companies
5
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
1
2
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Corcept TherapeuticsCA - Redwood City
3 programs1
1
1
RelacorilantPhase 31 trial
relacorilantPhase 21 trial
Dabigatran EtexilatePhase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Corcept TherapeuticsRelacorilant
RecordatiLCI699
Corcept Therapeuticsrelacorilant
Crinetics Pharmaceuticalsatumelnant
Corcept TherapeuticsDabigatran Etexilate
Clinical Trials (5)
Total enrollment: 337 patients across 5 trials
A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome
Start: Nov 2018Est. completion: Apr 2024152 patients
Phase 3Completed
Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
Start: Apr 2021Est. completion: Jul 202712 patients
Phase 2Recruiting
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
Start: May 2018Est. completion: Dec 2026125 patients
Phase 2Active Not Recruiting
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
Start: Oct 2023Est. completion: Oct 202618 patients
Phase 1/2Recruiting
Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants
Start: May 2022Est. completion: Jul 202230 patients
Phase 1Completed
Related Jobs in Endocrinology
Research Associate I/II - Biology
Marea Therapeutics
South San Francisco
1w ago
$90K - $120K/yr
Associate Director, Clinical Operations
Marea Therapeutics
South San Francisco
3w ago
$190K - $210K/yr
Associate Director/Director, Regulatory Affairs
Marea Therapeutics
South San Francisco
1mo ago
$185K - $240K/yr
Medical Science Liaison (rare diseases)
Amgen
Poland - Lódz
1mo ago
Senior/Executive Director, Analytical Development
Marea Therapeutics
South San Francisco
1mo ago
$250K - $295K/yr
Senior Clinical Scientist - Job ID: 1845
Ascendis Pharma
Palo Alto, California (Hybrid)
2mo ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
2 actively recruiting trials targeting 337 patients
3 companies competing in this space